ODDB.org: Open Drug Database

Mepha Pharma AG - Lecapon-Mepha 125 mg / 31.25 mg / 200 mg, Lactab

Swissmedic Registration	65283	Sequence	04
Product name	Lecapon-Mepha 125 mg / 31.25 mg / 200 mg	Description	Lactab
ATC-Classification	N04BA03	ATC-Description	Levodopa, Decarboxylase Inhibitor and Comt Inhibitor
Introduction of Sequence	25.03.2015

Composition

levodopum 125.0 mg, carbidopum 31.25 mg, entacaponum 200.0 mg, cellulosum microcristallinum, lactosum 80.0 mg, hydroxypropylcellulosum substitutum humile, povidonum, silica colloidalis anhydrica, magnesii stearas, Überzug: E 171, hypromellosum, glycerolum, E 172 (flavum), polysorbatum 80, E 172 (rubrum), magnesii stearas pro compresso obducto.

Packungsbestandteile

Galenic Form

Coated tablets

Active Agent	Dose
Carbidopa	31.25 mg
Entacapone	200 mg
Levodopa	125 mg

BAG: Active Agent	Dose
Carbidopa	31.25 mg
Entacapone	200 mg
Levodopa	125 mg

Inactive agents	Dose	additional_information
(Flavum)
(Rubrum)
Cellulosum Microcristallinum
E 171		Überzug
E 172		color.
Glycerol
Hydroxypropylcellulosum Substitutum Humile
Hypromellosum
Lactosum	80 mg
Magnesii Stearas
Magnesii Stearas pro Compresso Obducto
Polysorbatum 80
Povidone
Silica Colloidalis Anhydrica

Package number	Package Size	EFP	CP	Category	SL	Out of trade (MedRef)
007	30 Tablet(s)	19.36	37.45	B	SL	Yes
008	100 Tablet(s)	59.97	81.65	B	SL	Yes

2025	©ywesee GmbH